STBA

S&T Bancorp is a soundly run small regional bank, not a grower. Net income has plateaued — $145M (2023) → $131M (2024) → $134M (2025) — and FY2025's +2.3% rise in both net income and diluted EPS ($3.49) confirms a flat earnings profile. The 9.2% return on equity is mediocre for a bank; quality franchises typically clear 11–13%. What you're buying is balance-sheet strength and capital return, not growth. Leverage of 5.74x liabilities/equity is conservative versus most banks (often 8–10x), stockholders' equity grew 6.1% to $1.46B, and retained earnings rose 7.8% to $1.12B — the capital base is building faster than earnings.

The capital-return story is the real draw. Management is shrinking the share count aggressively: shares outstanding fell 4.5% in FY2025, $36.3M was spent on buybacks, and on January 22, 2026 the board replaced the prior plan with a new $100M repurchase program (expiring Feb 1, 2027) — roughly 5.6% of the ~$1.8B market cap — with $37.2M already executed at $43.45 by late February. Add the $0.36 quarterly dividend ($1.44 annualized, ~2.9% yield, with $52.9M paid in FY2025, up 3.8%) and the combined shareholder yield is high single digits. The MD&A frames the balance sheet as asset-sensitive — a −100bp shock trims pretax NII ~1.8% over 12 months — so a Fed easing cycle is a modest headwind to the core revenue engine, though EVE sensitivity has improved markedly versus 2024.